Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | MicrobiomeTrials← Back to trialsNCT05797246
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-08-02Est. Completion: 2027-07-31
Enrollment target: 21 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Lung NeoplasmsNeoadjuvant TherapyImmunotherapyMinimal Residual Disease
This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…
Beijing, ChinaEst. completion Oct 31, 2027
Rifampicin-Resistant Pulmonary TuberculosisMultidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, ChinaEst. completion Sep 29, 2028
Brain DeathRespiration, Artificial
This first-in-human pilot study will test an investigational miniature breathing device called the Hope inVent. The devi…
Philadelphia, United StatesEst. completion Dec 1, 2028